Skip to main content

View full-text article in PMC

. 2018 Feb 24;3(2):101–106. doi: 10.1136/svn-2018-000146

Table 4.

30-day morbidity and mortality in randomised trials comparing CEA and CAS in asymptomatic patients

30-day outcomes	Lexington³⁴		CREST-1*¹⁸		ACT-1³⁵		SPACE-2³³			Mannheim³⁶
30-day outcomes	CEA n=42	CAS n=43	CEA n=587	CAS n=364	CEA n=364	CAS n=1089	CEA n=203	CAS n=197	BMT n=113	CEA n=68	CAS n=68
Death/stroke	0%	0%	1.4%	2.5%	1.7%	2.9%	2.0%	2.5%	0.0%	1.5%	2.9%
Death/disabling stroke	0%	0%	0.3%	0.5%	0.6%	0.6%

*Only asymptomatic patients in CREST-1 were included.

ACT-1, Asymptomatic Carotid Trial 1; CAS, carotid artery stenting; CEA, carotid endarterectomy; SPACE, Stent-Protected Angioplasty versus Carotid Endarterectomy.